🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Status
Completed
Location
Hospital Universitario Príncipe de Asturias
Start Date
2020-11-04
Trial ID
NCT04687761
Treatments Being Tested
The vast majority of patients with ALL will die of the disease, and no stan...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2016-01-01
Trial ID
NCT03318419
Treatments Being Tested
The vast majority of patients with AML will die of the disease, and no stan...
Status
Unknown
Location
Liang Wang
Start Date
2016-01-01
Trial ID
NCT03181815
Treatments Being Tested
This phase I trial studies the side effects and the best dose of trebananib...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2011-10-31
Trial ID
NCT01555268
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficiency of autol...
Status
Active Not Recruiting
Location
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Start Date
2020-07-27
Trial ID
NCT04499573
Treatments Being Tested
This Phase 1/2 study will evaluate the safety, efficacy, PK, and PD of FT-2...
Status
Completed
Location
UCLA Medical Center
Start Date
2016-04-30
Trial ID
NCT02719574
Treatments Being Tested
QUESTIONS AND OBJECTIVES OF ALL-MB-2008 STUDY 1. Whether the early PEG-asp...
Status
Unknown
Location
Republican Research and Practical Center of Radiation Medicine
Start Date
2008-02
Trial ID
NCT01953770
This phase II trial tests how well venetoclax with cladribine and cytarabin...
Status
Recruiting
Location
University of Miami Miller School of Medicine-Sylvester Cancer Center
Start Date
2025-01-03
Trial ID
NCT06504459
The primary objective of this trial is to improve the overall survival rate...
Status
Recruiting
Location
Subang Jaya Medical Centre
Start Date
2020-03-04
Trial ID
NCT06336395
This is a Phase I/II clinical study to determine the maximum tolerated dose...
Status
Terminated
Location
Research Site
Start Date
2017-07-31
Trial ID
NCT03217838
Treatments Being Tested